These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19780905)

  • 1. Co-expression of Hif1alpha and CAIX is associated with poor prognosis in oral squamous cell carcinoma patients.
    Eckert AW; Lautner MH; Schütze A; Bolte K; Bache M; Kappler M; Schubert J; Taubert H; Bilkenroth U
    J Oral Pathol Med; 2010 Apr; 39(4):313-7. PubMed ID: 19780905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the Prognostic Role of Carbonic Anhydrase 9 (CAIX) of the Cellular mRNA/Protein Level or Soluble CAIX Protein in Patients with Oral Squamous Cell Carcinoma.
    Eckert AW; Horter S; Bethmann D; Kotrba J; Kaune T; Rot S; Bache M; Bilkenroth U; Reich W; Greither T; Wickenhauser C; Vordermark D; Taubert H; Kappler M
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters.
    Kappler M; Taubert H; Holzhausen HJ; Reddemann R; Rot S; Becker A; Kuhnt T; Dellas K; Dunst J; Vordermark D; Hänsgen G; Bache M
    Strahlenther Onkol; 2008 Aug; 184(8):393-9. PubMed ID: 18956515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase IX overexpression regulates the migration and progression in oral squamous cell carcinoma.
    Yang JS; Lin CW; Chuang CY; Su SC; Lin SH; Yang SF
    Tumour Biol; 2015 Dec; 36(12):9517-24. PubMed ID: 26130414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma.
    Brockton NT; Klimowicz AC; Bose P; Petrillo SK; Konno M; Rudmik L; Dean M; Nakoneshny SC; Matthews TW; Chandarana S; Lau HY; Magliocco AM; Dort JC
    Oral Oncol; 2012 Jul; 48(7):615-22. PubMed ID: 22366443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAI-1, CAIX, and VEGFA expressions as prognosis markers in oral squamous cell carcinoma.
    Peterle GT; Maia LL; Trivilin LO; de Oliveira MM; Dos Santos JG; Mendes SO; Stur E; Agostini LP; Rocha LA; Moysés RA; Cury PM; Nunes FD; Louro ID; Dos Santos M; da Silva AMÁ
    J Oral Pathol Med; 2018 Jul; 47(6):566-574. PubMed ID: 29693741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CA-IX is associated with advanced stage tumors and poor survival in oral squamous cell carcinoma patients.
    Pérez-Sayáns M; Suárez-Peñaranda JM; Pilar GD; Supuran CT; Pastorekova S; Barros-Angueira F; Gándara-Rey JM; García-García A
    J Oral Pathol Med; 2012 Oct; 41(9):667-74. PubMed ID: 22486898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipocalin 2 prevents oral cancer metastasis through carbonic anhydrase IX inhibition and is associated with favourable prognosis.
    Lin CW; Yang WE; Lee WJ; Hua KT; Hsieh FK; Hsiao M; Chen CC; Chow JM; Chen MK; Yang SF; Chien MH
    Carcinogenesis; 2016 Jul; 37(7):712-722. PubMed ID: 27207653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
    Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
    Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.
    Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Kawaoka K; Wong SG; Belldegrun AS; Pantuck AJ
    Cancer; 2009 Apr; 115(7):1448-58. PubMed ID: 19195047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature.
    Zhao Z; Liao G; Li Y; Zhou S; Zou H; Fernando S
    PLoS One; 2014; 9(11):e114096. PubMed ID: 25426861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix.
    Ellingsen C; Andersen LM; Galappathi K; Rofstad EK
    BMC Cancer; 2015 Oct; 15():805. PubMed ID: 26502718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients' prognosis.
    Chen Y; Li X; Wu S; Xu G; Zhou Y; Gong L; Li Z; Yang D
    Med Oncol; 2014 Dec; 31(12):304. PubMed ID: 25377659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer.
    Kock L; Mahner S; Choschzick M; Eulenburg C; Milde-Langosch K; Schwarz J; Jaenicke F; Müller V; Woelber L
    Int J Gynecol Cancer; 2011 Jan; 21(1):141-8. PubMed ID: 21330838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
    Andersen S; Eilertsen M; Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
    Lung Cancer; 2011 Jun; 72(3):294-302. PubMed ID: 21075472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX.
    Korkolopoulou P; Perdiki M; Thymara I; Boviatsis E; Agrogiannis G; Kotsiakis X; Angelidakis D; Rologis D; Diamantopoulou K; Thomas-Tsagli E; Kaklamanis L; Gatter K; Patsouris E
    Hum Pathol; 2007 Apr; 38(4):629-38. PubMed ID: 17367605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Kamei S; Deguchi T; Hirose Y
    Oncol Rep; 2008 Sep; 20(3):525-30. PubMed ID: 18695901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma.
    Klimowicz AC; Bose P; Petrillo SK; Magliocco AM; Dort JC; Brockton NT
    Br J Cancer; 2013 Oct; 109(7):1859-66. PubMed ID: 24008660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
    Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.